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ABSTRACT
Nucleophosmin (NPM1/B23) is a nucleolar protein
implicated in growth-associated functions, in
which the RNA binding activity of B23 plays essen-
tial roles in ribosome biogenesis. The C-terminal
globular domain (CTD) of B23 has been believed to
be the RNA binding domain because the splicing
variant B23.2 lacking the CTD binds considerably
less efficiently to RNA. However, the recognition
of target RNAs by B23 remains poorly understood.
Herein, we report a novel mechanism by which
B23 recognizes specific RNA targets. We observed
that the nucleolar retention of B23.3 lacking the
basic region of B23.1 was lower than that of B23.1
because of its low RNA binding activity. Circular
dichroism measurements indicated that the
basic region and adjacent acidic regions of B23
are intrinsically disordered regions (IDRs).
Biochemical analyses revealed that the basic IDR
alone strongly binds to RNA with low specificity.
The excessive RNA binding activity of the basic
IDR was restrained by intra-molecular interaction
with the acidic IDR of B23. Chemical cross-linking
experiments and fluorescent labeling of bipartite
tetracysteine-tagged proteins suggested that the
inter- and intra-molecular interactions between
the two IDRs contribute to the regulation of the
RNA binding activity of CTD to control the cellular
localization and functions of B23.
INTRODUCTION
The biological activities of proteins are often exerted
by structurally ordered domains; therefore, structure-
function analyses have been central in understanding
several biological processes. However, recent studies
have documented that the structurally disordered ﬂexible
domain in the native state [intrinsically disordered regions
(IDRs)] play crucial roles in the regulation of protein–
protein and protein–nucleic acid interactions (1). The
IDRs often adopt a structured conformation on binding
to their target molecules. For example, the N-terminal
transactivation domain in the transcription factor p53 is
intrinsically disordered and folded on binding to the Taz2
domain of the co-activator, p300 (2). In addition, several
DNA binding proteins containing zinc ﬁngers, helix–loop–
helix motifs and homeodomains have N- or C-terminal
extended IDRs that assist efﬁcient recognition and
binding to target sequences (3). Furthermore, various
post-translational modiﬁcations occur in the IDRs, sug-
gesting that the IDRs play an integral role in regulation
of the protein functions (4).
The nucleolar phosphoprotein NPM1/B23 is involved
in the regulation of pre-ribosome RNA (rRNA) transcrip-
tion, processing and pre-ribosome transport (5–7). In
addition, B23 plays important roles in the regulation of
centrosome duplication (8), genomic stability (9) and
response to cellular stresses (10). Because of its wide
range of functions, the deregulation of B23 functions is
closely associated with tumorigenesis (10). Mutations of
the C-terminal domain (CTD) of B23 are frequently
observed in normal karyotype adult acute myeloid
leukemia (11). Moreover, B23 overexpression is often
observed in solid tumors (12–17). Therefore, it is crucial
to understand the mechanism of B23 action.
We previously identiﬁed B23 as a factor involved in
adenovirus chromatin remodeling (18). B23 was found
to be involved not only in adenovirus chromatin
remodeling but also in the regulation of the cellular
rRNA gene chromatin to stimulate transcription (5). B23
mainly localizes in the nucleolus but shuttles between the
nucleolus, nucleoplasm and cytoplasm. Three splicing
variants of B23 were reported to be expressed in human
cells (19) (see Figure 1A). B23.1 is the longest variant and
the most studied protein among the B23 variants; B23.2
has 259 amino acids and lacks the C-terminal 35 amino
acids (dark gray bar with black dots); the third variant,
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Figure 1. Characterization of B23 variants. (A) Schematic representation of B23 splicing variants. Black, oligomerization domain; stripes, acidic
regions; black with white dots, basic region; dark gray with black dots, CTD. (B) Localization of EF-tagged B23 variants. HeLa cells were
transfected with vectors for expression of EF-B23.1, EF-B23.2 and EF-B23.3. Localization of the protein was observed by ﬂuorescent microscope.
Bar at the bottom indicates 10 mm. (C) FRAP analysis of B23 variants. The mobility of EF-B23 proteins expressed in HeLa cells as in Figure 1B were
examined by FRAP assay. The ﬂuorescence at the bleached nucleoli relative to that before bleaching (1.0) was calculated and plotted as a function of
time. The data were represented as mean values±SD from 15, 15 and 13 experiments for B23.1 (black), B23.2 (blue) and B23.3 (red), respectively.
The t1/2 of ﬂuorescence recovery was estimated by curve ﬁtting and graphically represented (right panel). P-values were calculated by t-tests and
indicated with **P< 0.01. (D) Immunoprecipitation of EF-tagged B23 variants. 293T cells expressing EF, EF-B23.1, EF-B23.2 and EF-B23.3 (lanes
1–4, respectively) were subjected to immunoprecipitation with anti-Flag tag antibody in the buffer containing 150mM (lanes 5–8) or 300mM (lanes
9–12) of NaCl. Precipitated proteins were separated by SDS–PAGE and detected with western blotting using anti-Flag tag, and -B23 antibodies
(bottom panels). RNAs co-precipitated with EF-tagged proteins were puriﬁed and separated on 6% denaturing PAGE and visualized by Gel Red
staining (top panel). Lane M indicates RNA molecular markers. (E) RNA binding activity of B23 variants. Recombinant GST-tagged B23 proteins
were analyzed by SDS–PAGE followed by CBB staining (top panel). Puriﬁed proteins (5 mg) were incubated in the absence or presence of total
RNA (10 mg) prepared from 293T cells and loaded on a 15–40% sucrose gradient. Proteins in fractions collected from the top were analyzed by
SDS–PAGE and visualized by CBB staining. For the experiments incubated with RNA, the amount of the B23 proteins in each fraction relative to
that of input was calculated and shown in graph (bottom panel).
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which we have named B23.3, has 265 amino acids and
lacks 29 amino acids in the basic amino acid-rich region
(shown as black bar with white dots in Figure 1A). B23
forms a pentamer and decamer through the N-terminal
oligomerization domain (black bar in Figure 1A) (20).
A recent study reported that the CTD of B23.1 forms
globular structure consisting of three a-helices, and its
destabilization abolishes its nucleolar localization (21).
Because B23.2 does not bind to RNA, CTD is believed
to be crucial for its RNA binding activity (22). It was also
shown that the CTD of B23 binds to G-quadruplex DNA,
and this activity is reinforced by at least 17 adjacent
residues located in the basic region (23,24). Several predic-
tion programs suggest that the acidic and basic regions in
the central part of B23 are IDRs. The two acidic regions
[acidic IDR (aIDR), stripe bar in Figure 1A] are import-
ant for the histone chaperone activity of B23; however, the
structure of this region and relationship to its RNA
binding activity have not been analyzed. Recently, it was
reported that a synthetic peptide derived from the basic
region of B23, which shows a typical random-coil
spectrum by circular dichroism (CD), stabilizes its CTD
(25). We previously demonstrated that the cdc2/cyclin B
kinase phosphorylates the basic IDR (bIDR) of B23.1,
and this phosphorylation signiﬁcantly decreases its RNA
binding activity (26). However, the mechanism by which
cdc2/cyclin B-mediated phosphorylation decreases the
RNA binding activity of B23.1 is currently unknown.
In this study, we examined the bIDR involved in the
regulation of the RNA binding activity of B23.1. We
observed that B23.3 lacking a part of the bIDR showed
signiﬁcantly lower RNA binding activity than B23.1.
Further analyses strongly suggested that the association
between acidic and bIDRs of B23.1 allowed its recognition
and binding to target RNAs.
MATERIALS AND METHODS
Cell culture and transfection
HeLa and 293T cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (Nacalai Tesque) supplemented
with 10% fetal bovine serum. Transient transfection
of plasmid DNA was performed using GeneJuice
(Novagen) according to the manufacturer’s instructions.
Antibodies Anti-B23 serum was generated in rabbit
using the His-B23.1-CR protein as an antigen. Anti-Flag
tag antibody (M2, SIGMA-ALDRICH) and anti-His tag
antibody (HIS-1, SIGMA-ALDRICH) were commercially
available.
Plasmids pEGFPC1-Flag-B23.1, pGEX2T-B23.1, and
pET14b-B23.1, pET14b-B23.1-C1 (used as B23.2),
pET14b-B23.1-C2 (used as B23.1-C188), pET14b-
B23.1-C3, and pEGFPC1-Flag-B23.2, pET14b-B23.2,
and pGEX2T-B23.2 and pET14b-B23.1-T4sD were
described previously (18,26–28). To construct pEGFP-
Flag-B23.3, the cDNA fragment was generated using a
two-step PCR based on the sequence NM_199185. In
the ﬁrst PCR, two DNA fragments for B23.1 (1–194)
and B23.1 (233–294) were ampliﬁed using T7 promoter
primer and 50-AGTGAAGAAAGGACAAGAATCCTT
CAAG-30 and T3 promoter primer and 50-ATTCTTGT
CCTTTCTTCACTGGCGCTTT-30, with pBS-Flag-
B23.1 as a template. The ampliﬁed DNA fragments were
used in the second PCR as templates with T7 and T3
promoter primers. Ampliﬁed DNA fragment was
digested by NdeI and BamHI and cloned into the same
sites of pET14b. The B23.3 cDNA was cloned into pBS-
Flag by NdeI and HindIII sites of pBS-Flag vector. The
Flag-B23.3 cDNA was cut out from pBS-Flag-B23.3 by
digestion with BamHI and subcloned into the same sites
of pGEX2T (GE Healthcare) or pEGFPC1 (Clonetech
Laboratories). To construct the expression vectors of
GST- or His-tag fusion protein if not otherwise specify,
cDNAs prepared as following were digested by BamHI
or NdeI and BamHI, and cloned into the same sites
of pGEX2T or pET14b, respectively. To construct
pGEX2T-B23.1-CR, pGEX2T-B23.1-CRA, pGEX2T-
B23.1-CRD and pGEX2T-B23.1-CR1, the cDNA frag-
ments were ampliﬁed by PCR using 50-AAGGATCCCA
TATGAAAGCGCCAGTGAAGAAA-30 and T7 termin-
ator primer, with appropriate templates. The B23.1-CR1.5
cDNA was ampliﬁed using 50-AAGGATCCCATATGAG
TTCTGTAGAAGACATTAA-30 and GEX-30 primer,
and pGEX2T-B23.1-CR as a template. To construct
pGEX2T-B23.1-A2, the cDNA fragment was generated
using a two-step PCR. Two DNA fragments were
ampliﬁed using the T7 promoter primer and 50-CTGGC
GCTTTAGCAGCAAGTTTTACTTT-30 and the T3
promoter primer and 50-ACTTGCTGCTAAAGCGCCA
GTGAAGAAA-30, with pBS-Flag-B23.1 as a template.
The second PCR and cloning into pGEX2T of this
fragment was performed as described earlier in the text.
To construct pGEX2T-A1A2, the cDNA was cut out
from pBS-Flag-B23-A (5) by digestion with BamHI
and subcloned into the same site of pGEX2T. The
B23.1-N and B23.2-N cDNA fragments were
ampliﬁed using 50-AAGAATTCAACATATGGAGGAA
GATGCAGAGTCAGA-30 and T7 terminator primer,
and pET14b-B23.1 and pET14b-B23.2 as templates. To
construct pET14b-B23.1-Nc, N-terminal Cys–Cys- (CC-)
tag was introduced by PCR using 50-AAGGATCCATAT
GTTGAACTGCTGCGAGGAAGATGCAGAGTCA-30
and T7 terminator primer, and pET14b-B23.1-N as a
template. To construct pET14b-B23.1-Cc and pET14b-
B23.1-NCcc, Cys–Cys- (CC-) tag was introduced by
PCR using 50-GCAGCAAGGTCCTTTTGGTGTTTTA
GGAG-30 and 50-GTAGAAGACATTAAAGCAAAAA
TG-30, and pET14b-B23.1-N and pET14b-B23.1-Nc as
templates. To construct pET14b-B23.1-Ccc, tetracysteine
(CCPGCC) tag was introduced by PCR using 50-GCAGC
ATCCTGGGCAGCAGTTCAAAGGTCCTTTTGGTG
TTTTAGGAGT-30 and 50-GTAGAAGACATTAAAGC
AAAAATG-30, and pET14b-B23.1-N as a template.
Ampliﬁed DNA fragments containing pET14b vector
sequence were phosphorylated with T4 polynucleotide
kinase (TOYOBO) for following ligation reaction.
pET14b-B23.2-Nc, pET14b-B23.2-Cc, pET14b-B23.2-
NCcc and pET14b-B23.2-Ccc were constructed with the
same procedure as pET14b-B23.1-N, using T7 promoter
primer and 50-GCCTAAGGATCCTTAACCACCTTTT
TCTATACTTGC-30, and appropriate vectors as
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templates. The fragments of pET14b-B23.1-C160, -C194,
-C206, -C223 and -C241, and pET14b-B23.1-A-C160,
-C194, -C206, -C223 and -C241 were ampliﬁed using T7
promoter primer and 50-ccggatccttaagcagcaagttttactttt
ttctg-30, 50-ccggatccttatttcttcactggcgctttttc-30, 50-ccggatcctt
acttttgtgcatttttggctgg-30, 50-ccggatccttattttgatcttggtgttgat
ga-30 and 50-ccggatccttaaggtccttttggtgttttagg-30, and
pET14b-B23.1 and pET14b-B23.1-A1A2 as templates,
respectively.
Puriﬁcation of recombinant proteins
For expression and puriﬁcation of recombinant proteins,
BL21 (DE3) was transformed with pGEX2T or pET14b
plasmids containing B23.1 mutant cDNAs. The trans-
formed Escherichia coli were grown at 37C until OD600
reached 0.4. Expression of the recombinant proteins was
induced by addition of isopropyl b-D-thiogalacto-
pyranoside at 30C for 3 h or at 18C for 16 h. For puri-
ﬁcation of GST-tagged proteins, sonicated bacterial
cell lysates were incubated with Glutathione sepharose
(GE Healthcare) in buffer A [50mM Tris–HCl (pH 7.9),
0.1% Triton X-100 and 0.1mM PMSF] containing
150mM NaCl. The resin was washed with buffer A con-
taining 500mM NaCl, treated with micrococcal nuclease
(MNase) (Nuclease S7, Roche Applied Science), and
extensively washed with buffer A containing 500mM
NaCl. GST-tagged proteins retained on the resin were
eluted in a buffer containing [20mM reduced glutathione,
100mM Tris–HCl (pH 7.9) and 120mM NaCl]. His-
tagged proteins were puriﬁed with HIS-Select Nickel
afﬁnity gel according to the method suggested by the
manufacturer (SIGMA-ALDRICH). Puriﬁed proteins
were dialyzed against buffer H [20mM Hepes–NaOH
(pH 7.9), 50mM NaCl, 0.5mM EDTA, 1mM DTT,
0.1mM PMSF and 10% Glycerol]. His-tagged proteins
used in proteinase digestion assays and FlAsH assays
were further puriﬁed by separation on SDS–PAGE
followed by extraction in a buffer containing [0.1%
SDS, 50mM Tris–HCl (pH 7.9), 0.1mM EDTA,
150mM NaCl and 5mM DTT] and precipitated with
acetone. Precipitated proteins were denatured in a buffer
containing [6M guanidine–HCl, 50mM Tris–HCl (pH
7.9) and 5mM DTT], refolded by dialysis against a
buffer containing [50mM Hepes–NaOH (pH 8.0),
12.5mM MgCl2, 100mM KCl, 0.2mM EDTA, 0.1%
NP40 and 1mM DTT] and dialyzed against buffer H.
The protein concentrations were estimated by comparison
with proteins in a standard molecular mass marker (Bio-
Rad) on SDS–PAGE stained with Coomassie Brilliant
Blue (CBB). Identity of a part of recombinant proteins
was conﬁrmed by matrix-assisted laser-desorption time-
of-ﬂight mass spectrometry (MALDI-TOF-MS), and the
purity of the proteins was also analyzed by SDS–PAGE
(Supplementary Figure S1). The phosphorylation of
recombinant proteins was performed as described in
(26), using mitotic cell extracts as an enzyme source
in a buffer containing [20mM Tris–HCl (pH 7.4),
10mM MgCl2, 50mM NaCl, 3mM ATP, 1mM b-D-
glycerophosphate, 1mM NaVO4 and 1mM NaF] at
37C for 1 h. After phosphorylation reaction, CaCl2
(ﬁnal 5mM) and MNase (Nuclease S7, Roche Applied
Science) were added, and proteins were incubated for
additional 30min followed by puriﬁcation using GST-
tag as described earlier in the text. Phosphorylation
status was examined by phospho afﬁnity gel electrophor-
esis using phos-tag (Wako Pure Chemical Industries)
(29) in the presence of Mn2+.
Immunoﬂuorescence and ﬂuorescence recovery after
photobleaching analysis
To observe the localization of B23 splicing variants, HeLa
cells were transiently transfected with EF-tagged B23
vectors. Eighteen hours after transfection, cells were
analyzed by ﬂuorescence microscope (Olympus, IX71N-
22FL/PH-TS). For ﬂuorescence recovery after photo-
bleaching (FRAP) analysis, HeLa cells were transiently
transfected with EF-B23.1, EF-B23.2 and EF-B23.3, and
grown on 35-mm glass base dishes (IWAKI). The dish was
set on inverted microscope (LSM EXCITER; Carl Zeiss
Microimaging, Inc.) in an air chamber containing 5%
CO2 at 37
C and analyzed as previously described (30).
The data were represented as mean values±SD from 15,
15, and 13 experiments for B23.1, B23.2, and B23.3,
respectively.
Immunoprecipitation
293T cells were transiently transfected with EF, EF-B23.1,
EF-B23.2 and EF-B23.3 with Gene Juice (Novagene).
Sixteen hours after transfection, the cells were collected
and sonicated in buffer A containing 150mM NaCl. The
cell lysates were incubated with anti-Flag M2 afﬁnity gels
(SIGMA-ALDRICH) in buffer A containing 150mM or
300mM NaCl and 35 units RNase inhibitor (Nacalai
Tesque). The resins were washed with the same buffer,
and treated with 10 units of DNase I (Invitrogen), and
washed extensively with the buffer same. The proteins
bound with the resin were eluted with buffer A containing
150mM NaCl and Flag peptide (SIGMA-ALDRICH),
separated by SDS–PAGE and analyzed by western
blotting. RNAs co-precipitated with EF-tagged proteins
were treated with proteinase K, puriﬁed with phenol-
chloroform extraction and ethanol precipitation and
separated by 6% denatured PAGE. RNAs were visualized
by Gel Red staining (Biotium).
Sucrose density gradient centrifugation assays
GST-tagged B23 proteins (5mg) preincubated in the
absence or presence of total RNA puriﬁed from 293T
cells (10mg) or total RNA alone (10 mg) (100ml) were
loaded on 15–45% sucrose density gradient in the buffer
containing [20mM Hepes–NaOH (pH 7.9), 50mM NaCl
and 0.5mM EDTA] (2.1ml). The samples were
centrifuged at 54 000 rpm for 2 h at 4C in S55S rotor
(Hitachi Koki, SC100GXII), and fractions (150ml) were
collected from the top. Proteins in each fraction were
separated by SDS–PAGE and visualized by CBB
staining. RNAs in each fraction were puriﬁed, separated
by 1% denatured agarose gel and visualized by Gel Red
staining. The distribution patterns of proteins and RNAs
were analyzed using CS analyzer (ATTO).
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CD spectral analysis
CD spectral analyses were performed using a JASCO
spectrometer J-710 instrument (JASCO Inc.) at room
temperature in the wavelength interval 190–260 nm.
Data were collected at 0.2 nm resolution, 20 nm/min
scan speed, 1.0 nm bandwidth and 2 s response using
0.1 cm path-length quartz cuvette. Data for each protein
collected from four scans were averaged. The signal was
converted to mean molar residue ellipticity in units of
mdeg cm2 dmol1. The concentration of His-tagged B23
proteins was 5 mM in 50mM sodium phosphate buffer
(pH 7.0).
Filter binding assays
Filter binding assays were performed as described (26).
RNAs used in this assay was puriﬁed from 293T cells
using Sepasol RNA I Super G (Nacalai tesque) and
treated with DNase I. Experiments performed with
doublet were repeated more than twice. The data were
represented as mean values±SD.
Mobility shift assays
GST-B23.1-A was incubated with GST-tagged B23.1-
CR1, B23.1-CR1.5 and B23.1-CR in 10 ml of buffer H
for 30min at room temperature. Incubated samples were
separated on 6% native-PAGE in 0.5 TBE and
visualized by CBB staining.
Trypsin digestion assays
His-B23.1 and His-B23.1 -A1A2 (2 mg) were incubated in
10 ml of 50mM phosphate buffer (pH 7.6) containing
Trypsin for 2min at 37C. The proteolysis was stopped
with the addition of 3.5 ml of 4SDS sample buffer and
incubation for 5min at 95C, and proteins were separated
by SDS–PAGE followed by western blotting using
anti-His tag antibody.
FlAsH labeling
Recombinant proteins containing Cys-tag (1.1, 2.2, 4.4,
6.6, 8.8 and 13.2mM, respectively) were mixed with
10 mM FlAsH-EDT2 (Toronto Research Chemicals) and
0.5mM EDT (Nacalai Tesque) in a buffer containing
[10mM Hepes–NaOH (pH 8.0), 100mM NaCl, 1mM
EDTA, 25mM Tris–HCl (pH 7.9)] in 384-well plate
(Corning). The ﬂuorescence emission at 535±5nm was
detected by Varioskan (Thermo Fisher Scientiﬁc).
Cross-link assays
His-B23.1 -N and His-B23.2 -N (15–45 pmoles)
were incubated in the buffer [20mM Hepes–NaOH
(pH 7.9), 50mM NaCl, 0.5mM EDTA, 10% Glycerol,
1mM DTT, 0.5mM PMSF] containing 0.1%
glutaraldehyde (10ml) for 10min at room temperature.
The reaction was stopped by the addition of 1 ml of 1M
Tris–HCl (pH 7.9) and 3.5ml of 4 SDS–PAGE sample
buffer, and incubation at 95C for 5min. Cross-linked
proteins were separated by SDS–PAGE and visualized
by CBB staining.
RESULTS
Localization and RNA binding activity of B23 splicing
variants
Three splicing variants of NPM1/B23, B23.1, B23.2 and
B23.3 are expressed in HeLa cells (Figure 1A). The third
variant, which we named B23.3, has not been
characterized thus far. We ﬁrst characterized the cellular
localization and biochemical activity of this variant
protein compared it with that of B23.1 and B23.2.
EGFP-Flag (EF)-tagged B23.1, B23.2 and B23.3 were
transiently expressed in HeLa cells, and their localization
was observed (Figure 1B). Consistent with previous obser-
vations (26), EF-B23.1 was primarily detected in the
nucleolus, whereas EF-B23.2 was detected in both the
nucleoplasm and nucleolus. EF-B23.3 was primarily
localized in the nucleolus, and it was also clearly
detected in the nucleoplasm. We subsequently examined
the nucleolar retention of B23 splicing variants using
FRAP assays (Figure 1C). EGFP signal in a small nucle-
olus was targeted for bleaching with a 488-nm laser line,
and the intensity of EGFP was measured every 0.5 s. The
recovery curves indicated that the mobility of B23.2 was
considerably faster than that of B23.1, and the half time
(t1/2) of EF-B23.1 and -B23.2 recovery was 5.48±1.80 s
and 2.33±0.96 s, respectively. This ﬁnding was consistent
with the previous observation that CTD plays a crucial
role in the nucleolar retention of B23 (21,26). Despite
intact CTD, the mobility of B23.3 was similar to that of
B23.2 (t1/2=2.11±1.02 s).
Localization and chromatin association of B23 are
closely related to its RNA binding activity (26,28).
Therefore, we examined the RNA binding activity of
B23 splicing variants in cells (Figure 1D). EF-tagged
B23 proteins were transiently expressed in 293T cells,
and immunoprecipitation assays were performed. Under
the assay conditions, EF-tagged B23 proteins were equally
precipitated (Figure 1D, bottom panels). RNAs co-
precipitated with EF-tagged proteins were extracted and
analyzed by denaturing polyacrylamide gel and agarose
gel electrophoresis (Supplementary Figure S2A).
EF-B23.1 co-precipitated with 28S, 5.8S and 5S rRNAs
as previously reported (28), but not with 18S rRNA,
whereas B23.2 did so inefﬁciently (lanes 6 and 7). rRNA
association of EF-B23.3 was signiﬁcantly lower than that
of EF-B23.1 in the presence of 150mM NaCl and was
hardly detectable in the presence of 300mM NaCl (lanes
10 and 12). The 28S, 5.8S and 5S rRNA binding activity
of EF-B23.3 was approximately half compared with
that of EF-B23.1 in the presence of 150mM NaCl
(Supplementary Figure S2B). To investigate the direct
RNA binding activity, we performed sucrose density
gradient centrifugation assays using GST-tagged recom-
binant proteins and total RNAs puriﬁed from 293T cells
(Figure 1E). All three proteins were recovered from the
low-density fractions in the absence of RNA (Figure 1E,
lanes 2–4). In the presence of RNA, GST-B23.1 was pri-
marily recovered from the 28S rRNA peak fractions
(Figure 1E, lanes 6–10 and Figure 3C). In contrast, frac-
tions of GST-B23.2 did not clearly change, regardless
of the presence of RNA. Although a minor population
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of GST-B23.3 was recovered from the 28S rRNA peak
fractions, the fractionation pattern of GST-B23.3 was
not signiﬁcantly changed by the presence of RNA.
Because the fractionation pattern of GST alone was not
affected by the presence of RNA and non-tagged and
GST-tagged B23.1 showed similar fractionation pattern
in the presence of RNA (Supplementary Figure S3A and
B), GST-tagging did not affect the RNA binding activity
of B23 proteins. These results indicate that not only CTD
but also the region lacking in B23.3 play important roles
in the RNA binding activity of full-length B23.1 in cells
and in vitro.
Central regions of B23 are intrinsically disordered
Recent studies showed that the IDRs regulate the func-
tions of structured regions, such as protein–protein or
protein–nucleic acid binding activity (1). The acidic and
basic regions of B23 have low mean hydrophobicity and
high net charge, properties known to be associated with
the disordered status. Therefore, we hypothesized that the
central acidic and basic regions are IDRs and contribute
to regulate the RNA binding activity of the structured
RNA binding domain, CTD. Computational prediction
of the disordered status by POODLE-I (http://mbs.cbrc.
jp/poodle/poodle-i.html) (31) showed that the central
region of B23 is IDR (Figure 2A). To conﬁrm this predic-
tion, we performed CD spectrum analyses with His-tagged
B23.1-C3 harboring the N-terminal oligomerization
domain, B23.1-N, and B23.1-CR1 harboring bIDR
(amino acids 1–119, 120–294 and 189–259, respectively)
(Figure 2B). Consistent with the reported structural data
demonstrating that the oligomerization domain of B23.1
consists of b-sheets (32), the spectrum recorded for His-
B23.1-C3 showed a negative peak at 215 nm (green
line). His-B23.1-CR1 showed a typical random-coil
pattern peaking at 195 nm (blue line), as previously
reported (25). The spectrum recorded for His-B23.1 -N
Figure 2. Structural analysis of aIDR and bIDR. (A) Prediction of disorder tendency of B23.1. B23.1 structure was schematically represented at the
top. The patterns in the scheme are as deﬁned in the legend of Figure 1A. Disorder tendency of B23.1 was predicted using POODLE-I. (B–D) CD
spectral analyses of B23 mutants. His-tagged B23 mutant proteins (5 mM) were analyzed. His-B23.1-C (green), His-B23.1-N (purple) and
His-B23.1-CR1 (blue) (B). His-B23.1-N (purple), His-B23.1-CR (blue) and His-B23.1-CR1.5 (light purple) (C). His-B23.1-N (purple) and
His-B23.2-N (pink) (D).
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showed negative peaks at 222 and 200 nm (purple line).
Because negative peaks at 222 and 208 nm and that
at 200 nm are indicative of a-helix and random-coil
structure, respectively, we inferred that His-B23.1 -N
contained both a-helix and random-coil structures.
Consistent with previous nuclear magnetic resonance
studies (24), the spectrum of B23.1-CR1.5 (amino acids
242–294) peaked at 222 and 208 nm (Figure 2C, light
purple line). When the sequences adjacent to CTD were
elongated (His-B23.1-CR and His-B23.1 -N), the peak at
208 nm shifted to 200 nm. In addition, the spectrum of
His-B23.2 -N (acidic and basic regions with a short
portion of CTD) showed a negative peak at 200 nm
(Figure 2D, red purple line). These results indicated that
the central region of B23 containing acidic and basic
regions was disordered in solution. To exclude the
possible contribution of His-tag to the B23 protein struc-
ture, we prepared non-tagged B23.1, B23-CR1, B23.1 -N
and B23.2 -N and compared their spectra with those of
His-tagged proteins (Supplementary Figure S4). In all
cases, the overall pattern of the spectra was similar,
although the peak at 200–210 nm of B23.1, B23-CR.1,
B23.1-N was slightly shifted to the left when His-tag
was added. Thus, we concluded that His-tag did not
signiﬁcantly affect B23 protein structure.
bIDR and CTD of B23.1 associate with RNA
To address the function of bIDR of B23, we ivestigated
the RNA binding activity of this region. Recent studies
indicated that in addition to CTD of B23.1, a part of
bIDR was required for its stable G-quadruplex DNA
binding activity (24). These results raised the possibility
that bIDR is also involved in the RNA binding activity
of B23. To test this hypothesis, GST-tagged B23.1-CR1
and B23.1-CR1.5 were puriﬁed (Figure 3A and B) and
examined for RNA binding activity using sucrose
density gradient centrifugation assays. In the absence of
RNA, GST-B23.1 and mutant proteins were recovered in
low-density fractions (Figure 3C, lanes 1–4). When total
RNA was subjected to a sucrose density gradient centri-
fugation assay, 28S and 18S rRNAs were recovered in
fractions 6–10 and 4–9, respectively (Figure 3C, right
top panel). GST-B23.1 preincubated with total RNAs
was recovered in the fractions yielding 28S rRNA
(Figure 3C, right panel). Consistent with this result, the
fractionation pattern of 28S rRNA but not of 18S rRNA
shifted slightly to the bottom (Figure 3D, top graphs),
suggesting that B23.1 preferentially associated with 28S
rRNA. When GST-B23.1-CR1 was preincubated with
RNA, its distribution pattern shifted to high-density frac-
tions (Figure 3C, left panel, lanes 5–10). In contrast, GST-
B23.1-CR1.5 was not clearly cofractionated with rRNAs.
Consistent with this result, GST pull-down assays showed
that GST-B23.1-CR1 efﬁciently precipitated both 18S and
28S rRNA but GST-B23.1-CR1.5 and GST did so inefﬁ-
ciently (data not shown). These results indicated that
bIDR had potential RNA binding activity and that
CTD alone could not efﬁciently associate with rRNAs.
Fractionation patterns of both 28S and 18S rRNAs
showed shifts to higher-density fractions when incubated
with the GST-B23.1-CR1 protein (Figure 3D). In
addition, 28S rRNA preincubated with CR1 shifted to
higher-density fractions than that preincubated with
wild-type B23.1. On the basis of these results, we predicted
that bIDR of B23.1 strongly associates with RNA with
low speciﬁcity.
B23.1 was recovered primarily in the 28S rRNA peak
fractions, but we did not know whether B23.1 directly
binds 28S rRNA. To investigate the same, we examined
the RNAs contained in the 28S peak fractions. Total
RNAs were fractionated by sucrose density gradient cen-
trifugation assay, and the RNAs were separated by
agarose gel and polyacrylamide gel electrophoresis
(Supplementary Figure S5A). 18S and 28S rRNAs were
recovered in fractions 4–9 and 6–10, respectively. In
addition, 5.8S rRNA and a small but distinct level of 5S
rRNA clearly cofractionated with 28S rRNA. To test
whether B23.1 directly binds to 28S but not to 18S
rRNA, both 28S and 18S rRNAs were puriﬁed. 18S and
28S rRNAs alone were primarily found in fractions 4–6
and 7–9, respectively. We next examined the 28S and 18S
rRNA binding activity of B23.1 by sucrose density
gradient centrifugation assay (Supplementary Figure S5B
and C). Surprisingly, we found that GST-B23.1 was
cofractionated with both puriﬁed 18S and 28S rRNAs.
However, when total RNAs were mixed with puriﬁed
18S rRNA and examined for B23.1 binding, GST-B23.1
recovery in the 18S rRNA peak fractions (fractions 4–7)
decreased and those in the 28 S rRNA peak fractions
(fractions 7–10) increased. These results suggest that
B23.1 has some preference for RNA structure or
sequence found in RNAs in the 28 S peak fractions such
as 28 S and 5.8 S rRNAs.
Phosphorylation of bIDR contributes to the inactivation of
B23.1 RNA binding activity
Previously, we have demonstrated that the phosphoryl-
ation of B23 by cdc2/cyclin B kinase reduces its RNA
binding activity (26). The phosphorylation sites, threonine
199, 219, 234 and 237, are located in bIDR. Consistent
with previous results (28), the phosphomimetic mutant of
four threonine residues (T4sD) (Figure 4A and B) showed
signiﬁcantly lower RNA binding activity than wild-type
B23.1 (Figure 4B). Therefore, we hypothesized that
mitotic phosphorylation regulated the RNA binding
activity of bIDR. To test this hypothesis, B23.1-CR was
phosphorylated by mitotic extracts prepared from
HeLa cells, and the RNA binding activity of phosphory-
lated protein was assessed (Figure 4C and D).
Phosphorylation status of the protein was examined by
Mn2+-phos-tag SDS–PAGE (compare lanes 1 and 2 in
Figure 4C). Although the CR protein was not completely
phosphorylated, the RNA binding activity of
phosphorylated GST-B23.1-CR was lower than that of
untreated GST-B23.1-CR (Figure 4D). To gain clearer
insight into this point, phosphomimetic (CRD) and
unphosphorylatable (CRA) mutants of GST-tagged
B23.1-CR, in which threonine (T) residues were replaced
with aspartic acid (D) and alanine (A) residues, respect-
ively, were expressed and examined for the RNA binding
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activity using ﬁlter binding assay (Figure 4E and F).
Labeled RNA was retained on the membrane when
incubated with GST-B23.1-CR and GST-B23.1-CRA
mutant proteins. However, the activity of GST-B23.1-
CRD was signiﬁcantly lower than that of GST-B23.1-
CR and GST-B23.1-CRA (30% of GST-B23.1-CR).
The GST pull-down assay also indicated that the 28 S
and 18 S rRNA binding activities of GST-B23.1-CRD
were 35 and 25% of those of GST-B23.1-CR
(Supplementary Figure S6). CD spectral analyses of the
three mutant proteins showed peaks at 222 and 208 nm,
the typical pattern of a-helix (Figure 4G and H), suggest-
ing that the phosphomimetic mutation at the phosphoryl-
ation sites does not affect the C-terminal helical structure.
Moreover, in the presence of a low concentration of RNA,
the CD spectrum of bIDR (CR1, see Figure 3B) was not
Figure 3. The RNA binding activity of bIDR and CTD of B23.1. (A) Schematic representation of B23.1 and mutants. The patterns in the scheme
are as deﬁned in Figure 1A. (B) Recombinant GST-tagged B23.1 and its mutant proteins were analyzed by SDS–PAGE followed by CBB staining.
Lane M indicates molecular markers. (C) Sucrose density gradient centrifugation assays. The RNA binding activities of GST-tagged B23.1 and
mutant proteins were examined by Sucrose gradient centrifugation as in Figure 1E. Proteins in fractions were analyzed by SDS–PAGE and visualized
by CBB staining (left panels). RNA alone (right top panel) and RNAs preincubated with B23 proteins were puriﬁed from each fraction, separated on
1% denatured agarose gels and visualized by Gel Red staining (right panels). (D) Distribution pattern of 28S and 18S rRNAs. The amounts of 28S
(left panels) and 18S rRNAs (right panels) in each fraction in Figure 3C right panels relative to total 28S and 18S rRNAs were calculated and shown
in graphs. Dashed lines in each graph indicate the sucrose gradient results of RNAs in the absence of proteins (Figure 3C, top right panel).
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Figure 4. The effect of mitotic phosphorylation on the RNA binding activity of bIDR. (A) Schematic representation of B23.1 and
unphosphorylatable or phospho-mimetic CR mutants. B23.1-T4sD is a mutant in which threonine residues shown by arrowheads are replaced
with aspartic acid (D), and B23.1-CRA and B23.1-CRD are B23.1-CR mutants in which the same residues are replaced with alanine (A) and aspartic
acid (D), respectively. (B) RNA binding activity of B23.1 and phospho-mimetic mutant. GST-B23.1 and GST-B23.1-T4sD (50, 100, 200 and 400 ng
for lanes 3–6, respectively) were mixed with (lanes 3–6) or without (lane 2) 32P-labeled total RNA (10 ng). RNA alone was also examined (lane 1).
The intensity of each spot was analyzed by FLA7000, and the RNA binding activity obtained with the same amount of B23 proteins were calculated
relative to that of B23.1 (1.0). The relative RNA binding activity at each protein amount was averaged. Means±SD obtained from twice of
duplicate independent experiments are shown (bottom panel). (C) Phosphorylation of GST-B23-CR. GST-B23.1-CR was incubated with mitotic
extracts in the absence (lane 1) or presence (lane 2) of 3mM ATP. The incubated proteins were analyzed by phos-tag SDS–PAGE and visualized by
CBB staining. (D) The RNA binding activity of GST, unphosphorylated GST-B23.1-CR and phosphorylated GST-B23.1-CR (pGST-B23.1-CR) were
examined for ﬁlter binding assays as in (B). The bound RNA for each amounts of GST (dashed line), GST-B23.1-CR (black line) and GST-B23.1-
CRD (gray line) were plotted and shown in the right panel. (E) Recombinant GST-tagged B23 proteins were analyzed by SDS–PAGE followed
by CBB staining. Lane M indicates molecular markers. (F) RNA binding activity of B23.1-CR mutants. Filter binding assays were carried out
as described in (B) using GST-B23.1-CR, -CRA and -CRD. The amount of RNA retained on the membrane with GST-B23.1-CR is set as 1.0.
Statistical P-values were calculated by t-tests and indicated with **P< 0.01. (G) Recombinant His-tagged B23.1-CR, -CRA and -CRD were analyzed
by SDS–PAGE and visualized by CBB staining. Lane M indicates molecular markers. (H) CD spectral analysis of B23.1-CR, B23.1-CRA and
B23.1-CRD. CD spectra of B23.1-CR (blue gray), B23.1-CRA (light purple) and B23.1-CRD (purple) (5 mM) were analyzed.
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signiﬁcantly changed (Supplementary Figure S7). This
ﬁnding suggests that a speciﬁc structure of bIDR is not
induced on binding to RNA.
bIDR of B23 showed strong RNA binding activity,
whereas B23.2, containing identical amino acid sequences
in this region, did not efﬁciently associate with RNA, sug-
gesting that the RNA binding activity of bIDR is
modulated by full-length B23 protein. Because B23 has
an aIDR, it is likely that negative charge of the aIDR
neutralizes the positive charge of bIDR. To examine this
possibility, we studied the effect of aIDR deletion on B23
RNA binding activity using B23.1 -A2, B23.1 -A1A2
and B23.1-AC1 (Figure 5A). Sucrose density gradient
centrifugation assays clearly showed that the aIDR
mutants associated with RNA (fractions 5–10). The frac-
tionation pattern of 28S and 18S rRNAs indicated that
the aIDR mutants associated with both rRNAs. The
fraction shifts in fractions of both rRNAs incubated
with GST-B23.1-A1A2 were more prominent than
those of RNAs incubated with the B23.1-CR1 mutant
(see Figure 3C and D), possibly due to the oligomer for-
mation of GST-B23.1-A1A2. In addition, both 28S and
Figure 5. aIDR is required for the proper RNA binding of B23. (A) Schematic representation of B23.1 and deletion mutants. (B) Recombinant GST-
tagged B23 mutant proteins were analyzed by SDS–PAGE and visualized by CBB staining. Lane M indicates molecular markers. (C) Sucrose density
gradient centrifugation assays. Total RNAs (10 mg) preincubated in the absence (top panel) or presence of GST-tagged B23 proteins (5 mg) were
loaded on a 15–40% sucrose gradient. Proteins in fractions collected from the top were analyzed by SDS–PAGE and visualized by CBB staining (left
panels). RNAs recovered in each fraction were analyzed as in Figure 3C (right panels). Right top panel is data for RNA alone. (D) Distribution
patterns of 28S and 18S rRNAs. The intensity of 28 and 18S RNAs in C, right panels were scanned and analyzed by CS analyzer (ATTO) and
graphically represented. Dashed lines are the sucrose gradient results of RNA alone.
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18S rRNAs incubated with GST-B23.1-A1A2 were
recovered in higher-density fractions than those incubated
with GST-B23.1-A2 (Figure 5C and D).
Furthermore, GST-B23.1-AC1 associated with
RNAs, as did GST-B23.1-A1A2, indicating that CTD
was not required for RNA binding when aIDR was
deleted. From these results, we concluded that the
RNA binding activity of bIDR is negatively regulated
by aIDR and that aIDR confers RNA binding speciﬁcity
on B23.1.
We subsequently tested whether the two regions
associated with each other. GST-tagged B23-A (amino
acids 120–188) was mixed with increasing amounts of
B23.1-CR1, B23.1-CR1.5, B23.1-CR, B23.1-CRA or
B23.1-CRD (Figure 6A and B), and the mixtures were
loaded on native PAGE (Figure 6C). GST-B23.1-A
migrated toward the cathode faster than other mutants
because of its negative charge (the theoretical pI of
aIDR is 3.6), whereas GST-B23.1-CR1, -CR, -CRA and
-CRD did not enter the gel (pI; 10.2, 10.0, 10.0 and 9.7,
respectively). When GST-B23.1-A was incubated with
increasing amounts of GST-B23.1-CR1, -CR or -CRA,
free form of GST-B23.1-A decreased and low-mobility
bands appeared (lanes 8–11, 16–19 and 20–23). In
contrast, addition of GST-B23.1-CR1.5 did not change
the mobility of GST-B23.1-A (lanes 12–15).
Furthermore, the binding activity of GST-B23.1-A with
GST-B23.1-CRD was lower than that of GST-B23.1-
CR1, -CR and -CRA (lanes 24–27). In addition, the
binding activity of GST-B23.1-CR phosphorylated by
mitotic extracts to GST-B23.1-A was weaker than that
of the unphosphorylated protein (Supplementary Figure
S8). These results indicate that aIDR regulates the non-
speciﬁc RNA binding activity of bIDR through direct
association. Moreover, phosphorylation in bIDR dimin-
ished the RNA binding activity and the interaction with
aIDR. To assess the association between aIDR and bIDR
in full-length B23.1, we tested the sensitivity of His-tagged
B23.1 and B23.1-A1A2 toward trypsin (Figure 6D).
Digested peptides were detected by anti-His-tag antibody
to map digested sites. A series of C-terminal deletion
mutants (His-B23.1-C160, -C188, -C194, -C206, -C224
and -C241, and a corresponding set of mutants His-
B23.1-A1A2-C160, -C194, -C206, -C224 and -C241)
was used as size markers. On treatment with trypsin,
full-length B23.1 proteins decreased, whereas four
digested bands were detected by anti-His tag antibody.
The digested bands d and d’ were lower than those of
His-B23.1-C160 (amino acids 1–160) and His-B23.1-
A1A2-C160, suggesting that the bands d/d’ correspond
to the product digested at amino acids 140–150. The sizes
of bands a/a’, b/b’ and c/c’ were similar to those of the
C223, C194 and C160 mutants, respectively. The
intensities of the bands a, b and c relative to full-length
proteins were lower than those of a’, b’ and c’ relative to
full-length His-B23.1-A1A2. These results strongly
suggest that bIDR and the region 133–160 of B23.1 are
susceptible to trypsin degradation when aIDR is deleted.
These results support the idea that aIDR of B23.1 regu-
lates its bIDR by direct binding in its native full-length
form.
Inter- and intra-molecular interaction between IDRs
in B23
bIDR of B23.1 was essential for efﬁcient RNA binding
activity, although the RNA binding activity of the same
amino acid sequences (bIDR) in B23.2 was suppressed.
Therefore, we hypothesized that the interaction mode of
acidic and bIDRs in B23.1 was different from that in
B23.2. In addition, it was unclear whether the interaction
between the two IDRs was inter- or intra-molecular.
To address these points, we tested the interaction
between the two IDRs of B23 proteins using FlAsH
labeling (Figure 7A–D). FlAsH, a biarsenical dye, ﬂuor-
esces on binding to the thiol moieties of cysteines (Cys)
in the tetracysteine (Cys–Cys–Xaa–Xaa–Cys–Cys) (33). If
tetracysteine is separated into two Cys–Cys pairs, FlAsH
ﬂuoresces only when two Cys–Cys pairs are in close prox-
imity (6–8 A˚) (33,34). For this assay, we constructed a
series of B23.1-N and B23.2-N mutants containing
Cys–Cys tags (Figure 7A). One Cys–Cys tag was
introduced at the N-terminal of aIDR (B23-Nc and
B23.2-Nc), and the other was introduced at positions
242 and 243 (both serines) located at the border between
bIDR and CTD (B23.1-Cc and B23.2-Cc). The ‘-NCcc’
proteins have two Cys–Cys tags at both sites. B23.1-Ccc
and B23.2-Ccc, in which serines at 242 and 243 were
replaced with the known FlAsH binding tetracysteine
sequence (Cys–Cys–Pro–Gly–Cys–Cys) (35), were used
as positive controls (Figure 7A and B). When increasing
amounts of B23.2-Ccc were mixed with FlAsH, ﬂuores-
cence was detected in a dose-dependent manner
(Figure 7C). Fluorescence was also detected when B23.1-
Ccc was examined. However, the ﬂuorescence intensity of
B23.1-Ccc was only 10% of that of B23.2-Ccc
(P< 0.0005). This result suggests that CTD of B23.1 re-
stricted the access of FlAsH molecule to the tetracysteine
sequence located between bIDR and CTD. When
increasing amounts of B23.1-Nc, B23.1-Cc, B23.2-Nc
and B23.2-Cc harboring a single Cys–Cys pair were
mixed with FlAsH, very weak ﬂuorescence was detected
(Figure 7D). A mixture of B23.1-Nc and B23.1-Cc or of
B23.2-Nc and B23.2-Cc also showed weak ﬂuorescence
(Figure 7D). In contrast, in case of B23.1-NCcc and
B23.2-NCcc harboring two Cys–Cys pairs, ﬂuorescent
signals were dependent on protein concentration. These
results suggest that both B23.1-N and B23.2-N bent
to form a hairpin-like structure, and the two Cys–Cys
pairs in one molecule were located close to each other.
Although we could not detect inter-molecular interaction
using FlAsH labeling, it was possible that it could not be
detected because of the distance between the two Cys–Cys
pairs. To examine this possibility, chemical cross-link
assays were performed (Figure 7E). His-tagged B23.1-
N and B23.2-N were cross-linked with 0.1%
glutaraldehyde and separated using SDS–PAGE,
followed by CBB staining. Both His-B23.1-N and His-
B23.2-N were found to be monomers at low protein
concentrations because of the absence of the N-terminal
oligomerization domain (Figure 7E, lanes 1 and 2). Bands
corresponding to dimers appeared when His-B23.1-N
protein concentration was increased, whereas the dimer
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Figure 6. Association between two IDRs. (A) Schematic representation of B23 and deletion mutants. (B) Recombinant GST-tagged B23
mutant proteins were analyzed by SDS–PAGE and visualized by CBB staining. Lane M indicates molecular markers. (C) Mobility shift assays.
GST-B23.1-A (0.5 mg) mixed with increasing amounts of GST-B23.1-CR1 (lanes 8–11), GST-B23.1-CR1.5 (lanes 12–15), GST-B23.1-CR (lane 16–19),
GST-B23.1-CRA (lanes 20–23) and GST-B23.1-CRD (lanes 24–27) (0.5, 1.0, 2.0, and 4.0 mg) were incubated for 30min, separated by 6% native
PAGE in 0.5 TBE, and visualized by CBB staining. (D) Trypsin digestion of B23.1 and B23.1 -A1A2. His-B23.1 (lanes 7–11) and His-
B23.1 -A1A2 (lanes 12–16) were incubated with trypsin (0, 2, 8, 20 and 40 ng) for 2min at 37C, and digested proteins were separated on
SDS–PAGE and detected with western blotting using anti-His-tag antibody. As references for the digestion sites, a series of C-terminal deletion
mutants (lanes 1–6 and 17–21) were also separated by the same SDS–PAGE. C160, C188, C194, C206, C223 and C241 indicate B23.1 or
B23.1 -A1A2 proteins containing amino acids 1–160, –188, –194, –206, –223 and –241, respectively. Amino acid numbers are from the full-
length protein. The digested peptides of His-B23.1 and His-B23.1-A1A2 are indicated by a–d and a’–d’, respectively. B23.1 amino acids
141–294 are shown at the bottom. Putative digestion sites (a/a’, b/b’ and c/c’) are mapped by black arrowheads. Dashed underline, black underline
and double underline indicate aIDR, bIDR and CTD, respectively.
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Figure 7. Intra- and inter-molecular interaction between two IDRs of B23.1 and B23.2. (A) Schematic representation of B23 mutants. B23.1/B23.2-
N and their Cys–Cys-tagged mutants are schematically represented. The patterns in the scheme of B23.1-N are as deﬁned in Figure 1A.
N-terminal Cys–Cys tag was represented as CC- (Cys–Cys-). C-terminal Cys-Cys-tag was introduced by replacement of serines [S] 242 and 243
with cysteines [C], and represented as -CC-. Tetracysteine-tag (Cys–Cys–Pro–Gly–Cys–Cys, CCPGCC) was introduced into the same site with -CC-.
(B) Puriﬁed proteins. The Cys-Cys-tagged mutant proteins (200 ng) as indicated at the top of each lane were separated by SDS–PAGE and visualized
with CBB staining. (C) FlAsH labeling of B23.1-Ccc and B23.2-Ccc. His-tagged B23.1-Ccc (diamond) or B23.2-Ccc (square) (1.1, 2.2, 4.4, 6.6, 8.8
and 13.2 mM) was incubated with 10 mM of FlAsH-EDT2 for 30min at room temperature, and the ﬂuorescence intensity was recorded with
Varioskan. (D) FlAsH labeling of B23 mutants. His-tagged B23-Nc (light blue), B23-Cc (pink), B23-NCcc (purple) and mixture of B23-Nc and
B23-Cc (light purple line) [1.2, 2.4, 4.9, 7.3, 9.7 and 14.4mM (B23.1), or 1.1, 2.2, 4.4, 6.6, 8.8 and 13.2mM (B23.2)] were examined for FlAsH labeling
assay as in (B). (E) Cross-link assay. His-tagged B23.1-N and B23.2-N (1.5, 3.0 and 4.5 mM) (lanes 1 and 2, 3 and 4 and 5 and 6) were incubated
in the presence of 0.1% Glutaraldehyde for 10min, separated on SDS–PAGE, and visualized by CBB staining. Positions of size markers are
indicated at the left of the panel. (F) A model for B23.1-N and B23.2-N structures. The globular structure of CTD is illustrated by circle,
and stripes and black with white dots bars indicate aIDR and bIDR, respectively.
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formation of His-B23.2-N was inefﬁcient (Figure 7E,
lanes 5 and 6). This result suggests that inter-molecular
interaction between aIDR and bIDR in B23.1 occurs
more frequently compared with that in B23.2. Monomer
forms of these proteins were likely to form intra-molecular
interactions as shown by FlAsH labeling assays
(Figure 7D). Therefore, we conclude that aIDR and
bIDR of both B23.1-N and B23.2-N interact intra-
molecularly, and that B23.1-N also has the potential
to form inter-molecular interactions (Figure 7F).
DISCUSSION
In this study, we investigated the molecular mechanism by
which B23.1 associates with RNA. CD spectral analysis
revealed that the central acidic and basic regions of B23
were intrinsically disordered (Figure 2). Our results
suggest that B23.1 recognizes RNA through two frag-
ments, bIDR and CTD, and that aIDR modulates the
non-speciﬁc RNA binding activity of bIDR, allowing
B23 CTD to recognize and interact with target RNAs.
In the absence of CTD, the non-speciﬁc RNA binding
activity of bIDR was inhibited by aIDR, indicating that
B23.2 inefﬁciently associates with RNA. This model is
based on three ﬁndings: (i) bIDR binds directly to
RNAs (Figures 3 and 4); (ii) the RNA binding activity
of bIDR of B23 is regulated by its aIDR (Figures 5 and
6); and (iii) the association mode of the acidic and bIDRs
is different between B23.1 and B23.2 (Figure 7). The regu-
latory functions of IDRs could be biologically important
because bIDR deletion (B23.3) increased and aIDR
deletion (B23.1-A1A2) decreased cellular mobility of
B23 (Figure 1C and Supplementary Figure S9).
CTD of B23.1 is known as the DNA and RNA binding
domain. Recent studies have shown that the small groove
formed by the ﬁrst two a-helices in CTD recognizes the
phosphate group of the G-quadruplex DNA (24). Basic
amino acids located at the surface of CTD allow electro-
static interaction with DNA. The afﬁnity of CTD alone
to G-quadruplex DNA was weak (KD> 1 105M), but
it increased on addition of ﬂanking sequences (KD was
2 106M) (23). Consistent with this, the RNA
binding activity of CTD was low, and full bIDR was
required for efﬁcient RNA binding by CTD. In the
complex with G-quadruplex DNA, bIDR does not
directly associate with DNA (24), and the role of bIDR
is inferred to stabilize the structure of CTD (25). In this
study, we found that bIDR alone could bind to RNA
(Figure 3), and B23.3 lacking most of bIDR showed
signiﬁcantly lower RNA binding activity than B23.1
(Figure 1). These results indicate that bIDR is required
for the RNA binding activity of B23.1. This activity of
bIDR is likely to help CTD to identify and recognize
target RNA sequences or structures by direct binding to
RNA. Considering that CTD preferentially binds to
structured RNA or DNA, bIDR may stabilize the
binding by interacting with ﬂanking RNA/DNA
sequences. The RNA recognition mode of B23.1 is
extremely similar to that used by several transcription
factors and the linker histone H1. For example, histone
H1 binds to the nucleosome at the DNA entry and exit
sites through its central globular domain (36,37). In
human cells, the absence of the basic C-terminal ID
region of histone H1 signiﬁcantly decreases the ﬂuorescent
recovery time after photobleaching (18.7±5.7 s for the
wild-type and 0.49±0.11 s for the deletion mutant) (38).
It is suggested that the C-terminal ID region confers
the stable nucleosome binding activity on histone H1 by
interacting with the linker DNA region between the
nucleosomes.
Here we show that full-length B23.1 seems to bind pref-
erentially to 28S rRNA through its CTD. However, which
sequence or structure in the RNA is recognized by B23 is
currently unknown. It has been reported that B23 binds to
G-quadruplex DNAs (39). Because G-rich RNAs also
form G-quadruplex structures, G-rich RNA regions
are possibly those recognized by B23. Both 18S and
28S rRNAs have G-rich sequences predicted to form
G-quadruplex structures (data not shown), and both
puriﬁed rRNAs are associated with B23 (Supplementary
Figure S5B). Of interest, 18S rRNA binding of B23
decreased on total RNA addition. These results suggest
that the RNA structure or sequence in 18S rRNA
targeted by B23 is disrupted or hindered by other RNA
species. It is also possible that B23 associates with 28S
rRNA complexed with other RNA species with much
higher afﬁnity than that with18S rRNA or 28S rRNA
alone. It is well established that 28S rRNA is strongly
bound to 5.8S rRNAs by hydrogen bonds (40,41). Thus,
double-stranded region of the 28S–5.8S rRNAs may be
recognized by B23.
B23.2 lacking CTD did not efﬁciently associate with
RNA (Figure 1). We assume that the RNA binding
activity of bIDR of B23.2 was completely inhibited by
aIDR possibly because of the hairpin-like structure forma-
tion (see Figure 7F). Intra-molecular interaction between
these regions may be physically hindered by CTD in full-
length B23.1, and this interaction becomes more dynamic
and inter-molecular between adjacent molecules. This
hypothesis was supported by the observation that the
accessibility of the FlAsH ﬂuorophore to the site between
bIDR and CTD was restricted in B23.1-Ccc (Figure 7C).
Previously, we have demonstrated that B23.1–B23.2 and
B23.1–NPM3 hetero-oligomers show lower RNA binding
activity than that by the B23.1 homo-oligomer (26,30).
B23.2 or NPM3 incorporation in the B23.1 oligomer may
decrease the chance to establish inter-molecular inter-
actions between adjacent molecules of B23.1, possibly
inhibiting bIDR function by aIDR. It should also be men-
tioned that the stochastic interaction between the two IDRs
increases depending on protein concentration. Because B23
forms a pentamer or decamer in solution, the local concen-
tration of IDRs is increased, and this may allow inter-
molecular interactions in B23.1 homo-oligomers. Given
that two B23 pentamers form a decamer in a head-to-
head fashion (20,32), two possible interaction modes can
be considered: One is that bIDR associates with aIDR of
a neighboring protein in a pentamer and the other is that
bIDR associates with aIDR in the other pentamer (see
Supplementary Figure S10).
B23 is known to be subjected to various post-
translational modiﬁcations including phosphorylation,
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acetylation and sumoylation (26,42–47). Our results
clearly explained why mitotic phosphorylation by cdc2/
cyclin B kinase at bIDR decreases the RNA binding
activity. It has been reported that lysines at positions
257 and 267 of B23.1 located at the surface of CTD (24)
are acetylated by p300 and that these acetylations induce
the translocation of B23.1 from the nucleolus to the nu-
cleoplasm (46). Because the G-quadruplex DNA and
RNA binding activity of B23.1 strongly affect its nucleolar
localization (28,39), it is likely that acetylation reduces the
DNA/RNA binding activity by neutralizing the positive
charge required for its contact with target sequences.
Ser125 located in aIDR is known to be phosphorylated
by casein kinase 2 (43). Previous studies have
demonstrated that phosphorylation of Ser125 decreases
the RNA binding activity (28) and nucleolar retention
time of B23.1 (48). We hypothesize that the increased
negative charge in aIDR by phosphorylation augments
its afﬁnity to bIDR, resulting in the decreased DNA/
RNA binding activity of bIDR. In summary, post-
translational modiﬁcations in aIDR, bIDR and CTD all
affect the DNA/RNA binding activity of B23.1.
Regulation of B23.1 functions by post-translational modi-
ﬁcation is mechanistically explained by the inter- or intra-
molecular interactions between the two IDRs. Moreover,
because these regulatory regions are IDRs, the accessible
surface area of modiﬁcation enzymes is believed to be
larger than the structured domains, thereby rapidly
regulating the functions of B23.1. Thus, these modiﬁca-
tions contribute to ﬁne-tuning the B23.1 functions to
control proper cell growth and proliferation.
B23 associates with various proteins in cells, such as
p14ARF (49), histones (27,50) and p53 (51,52), through
its N-terminal domain, aIDR and bIDR, respectively.
Because the RNA binding activity of B23.1 is regulated
by the association between acidic and bIDRs, it is
presumed that when bIDR of B23.1 is occupied by
RNA or aIDR is occupied by histones, the association
of the two IDRs is disturbed. These interactions with
other molecules may reciprocally increase the afﬁnity of
these regions for target molecules. Therefore, it is likely
that B23.1 tethered by RNA molecules on chromatin
around the rRNA gene (28) functions as an active
histone chaperone.
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